Nov 5, 8:06 AM ET
Vericel reported third quarter 2026 total revenue up 26% to $85.4 million and net income up 179% to $14.2 million, or $0.27 per diluted share. The company raised its full-year 2026 total revenue guidance to $344 million to $346 million from $330 million to $340 million.
- Q3 2026 total net revenue of $85.4 million, up from $67.5 million in Q3 2025
- Net income of $14.2 million, or $0.27 per diluted share, versus $5.1 million, or $0.10 per diluted share, a year earlier
- Full-year 2026 revenue guidance raised to $344 million to $346 million; MACI guidance raised to $290 million to $292 million
- Adjusted EBITDA margin guidance raised to 28% from 27%; repurchased 220,744 shares for $8.8 million in the quarter
Read the filing on SEC.gov ↗
Jul 30, 8:03 AM ET
Vericel reported second quarter 2026 total revenue of $77.5 million, up 22% from a year earlier, and net income of $2.2 million, or $0.04 per diluted share, compared with a net loss of $0.6 million in the same quarter of 2025. The company raised its full-year 2026 total revenue guidance to $330 million to $340 million and authorized a $200 million share repurchase program.
- Q2 2026 total revenue was $77.5 million, up from $63.2 million; MACI net revenue was $65.5 million
- Net income was $2.2 million, or $0.04 per diluted share, versus a net loss of $0.6 million in Q2 2025; gross margin was 73% versus 74%
- Full-year 2026 total revenue guidance raised to $330 million to $340 million from $326 million to $336 million
- Board authorized a $200 million share repurchase program; the company reported approximately $227 million in cash and investments and no debt
Read the filing on SEC.gov ↗
May 7, 7:57 AM ET
Vericel reported first quarter 2026 total revenue of $68.4 million, up 30% from $52.6 million a year earlier, and its net loss narrowed to $6.3 million, or $0.12 per diluted share, from $11.2 million, or $0.23 per share. The company raised its full-year 2026 total revenue guidance to $326 to $336 million from $316 to $326 million, which signals higher expected sales for shareholders.
- Total revenue of $68.4 million, up 30% from $52.6 million in the first quarter of 2025
- Net loss of $6.3 million, or $0.12 per diluted share, compared with $11.2 million, or $0.23, a year earlier
- Full-year 2026 total revenue guidance raised to $326 to $336 million; Burn Care guidance raised to $44 to $48 million from $36 to $40 million
- Free cash flow of $15.1 million; approximately $211 million in cash and investments and no debt
Read the filing on SEC.gov ↗
Feb 26, 8:02 AM ET
Vericel reported fourth-quarter 2025 total revenue of $92.9 million, up 23%, and net income of $23.2 million, up 17%. For the full year, revenue rose 16% to $276.3 million and net income rose 59% to $16.5 million. The company guided 2026 total revenue to $316 million to $326 million and MACI revenue to $280 million to $286 million.
- Q4 2025 net income was $23.2 million, or $0.45 per diluted share, versus $19.8 million, or $0.38, in Q4 2024
- Full-year 2025 net income was $16.5 million, or $0.32 per diluted share, versus $10.4 million, or $0.20, in 2024
- 2026 guidance: total revenue of $316 to $326 million, gross margin of about 75%, and adjusted EBITDA margin of about 27%
- Operating expenses rose to $50.7 million in Q4 2025 from $40.0 million, mainly from headcount and costs tied to the new Burlington facility
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.